# Recipharm

Recipharm（成立于 1995，瑞典）在美投资无菌生产、新建 BFS 产线及 Leganés 高活性 OSD，强化准入布局。

Source: https://cn.bioecon.ru/companies/recipharm/
Updated: 2026-06-24

- 国家: Sweden

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | €8.27亿（2024 年） | https://firstwordpharma.com/story/5942160, https://www.recipharm.com/press-releases/recipharm-reports-record-2024-revenue-and-strategic-milestones |
| 员工人数 | 超过5,000名员工 | https://www.recipharm.com/press-releases/recipharm-reports-record-2024-revenue-and-strategic-milestones, https://www.recipharm.com/press-releases/recipharm-strengthens-high-potency-capabilities-new-pilot-and-development-investment |
| 生产基地 | 全球网络包括法国、德国、印度、以色列、意大利、摩洛哥、葡萄牙、西班牙、瑞典和美国的工厂 | https://www.recipharm.com/press-releases/recipharm-reports-record-2024-revenue-and-strategic-milestones, https://www.recipharm.com/sites/recipharm-corp/files/recipharm/recourse/Recipharm-sterile-capabilities.pdf, https://www.recipharm.com/sites/recipharm-corp/files/recipharm/recourse/brochure/RecipharmFullServiceOffering_2026.pdf, https://www.recipharm.com/sites/recipharm-corp/files/recipharm/sustainability/sustainability-reports/Recipharm_Sustainability_report_2024.pdf |
| 融资 | 在美国无菌生产、新的 BFS 生产线以及莱加内斯（2026年）高活性固体制剂（OSD）能力方面投入数百万美元 | https://www.recipharm.com/press-releases/recipharm-boosts-bfs-capacity-strategic-manufacturing-investment, https://www.recipharm.com/press-releases/recipharm-expands-us-sterile-fill-and-finish-capabilities-support-growing-demand-biologics-and-advanced-therapies, https://www.recipharm.com/press-releases/recipharm-strengthens-high-potency-capabilities-new-pilot-and-development-investment |
| 监管批准 | 2024年获得多项FDA及全球监管批准 | https://www.recipharm.com/press-releases/recipharm-reports-record-2024-revenue-and-strategic-milestones |
| 监管批准 | Leganés工厂获FDA批准,并持有AEMPS、ANVISA、EMA、PMDA及MFDS认证 | https://www.recipharm.com/about-us/locations/leganes |
| 产能 | 在欧洲及美国扩大预充式注射器(PFS)及冻干产能;Wasserburg厂区提供超过6000万支PFS及西林瓶产能;在美国新增超过1亿件即用型无菌单位 | https://www.recipharm.com/press-releases/recipharm-boosts-bfs-capacity-strategic-manufacturing-investment, https://www.recipharm.com/press-releases/recipharm-reports-record-2024-revenue-and-strategic-milestones |

独立来源: firstwordpharma.com

## 技术

- [面向市场准入的本地化生产](https://cn.bioecon.ru/technology/local-manufacturing-for-market-access/)